Representative Newhouse Purchases $1k–$15k of Synopsys Shares as Stock Gains 1.6%
Representative Dan Newhouse filed on January 15 that he bought $1,001–$15,000 of Synopsys shares in his Edward Jones IRA on December 31. Synopsys shares rose 1.61% in the latest trading session.
1. Congressional Purchase of Synopsys Shares
Representative Dan Newhouse (R-Wash.) disclosed in a January 15 filing that he purchased between $1,001 and $15,000 worth of Synopsys shares on December 31 through his Edward Jones IRA account. This marks the latest in a series of trades by Newhouse dating back to November, reflecting continued interest in technology and financial stocks within his retirement portfolio. The purchase aligns with increased legislative focus on semiconductor competitiveness and supply-chain resilience.
2. Q4 Earnings Beat and Updated Guidance
In its December quarterly report, Synopsys delivered adjusted EPS of $2.90, surpassing consensus estimates by $0.11, on revenue of $2.25 billion, matching analysts’ forecasts and representing a 37.8% year-over-year increase. Return on equity reached 7.9% and net margin stood at 18.9%. Management set full-year 2026 EPS guidance in the range of 14.320 to 14.400 and Q1 EPS guidance of 3.520 to 3.580, compared with an average analyst projection of 10.64 EPS for the current fiscal year.
3. Institutional and Insider Transactions
During the latest reporting periods, Stanley Laman Group increased its holdings by 542.9%, adding 10,874 shares valued at $6.35 million, while Symphony Financial raised its stake by 4,780.9%, acquiring 39,395 shares for $20.64 million. Bank of New York Mellon added 4,815 shares, a 0.4% increase, and Westbourne Investments initiated a $1.505 million position. Mirae Asset grew its stake by 1.7%, adding 2,991 shares. Insiders have sold a total of 4,157 shares worth $1.945 million over the past 90 days, including CFO Shelagh Glaser’s sale of 3,657 shares for $1.685 million on December 19 and Janet Lee’s sale of 250 shares for $132,500 on January 12, leaving insiders with 0.62% ownership.
4. Analyst Consensus and Price Targets
Nine research firms maintain Buy ratings on Synopsys, seven have Hold ratings and one issues a Sell, resulting in a consensus Hold rating. The average price target stands at $553.57. Notable recent actions include Citigroup initiating coverage with a Buy rating and a $580 target, Morgan Stanley raising its target from $510 to $550 while assigning an Overweight rating, and upgrades from Zacks Research and Wall Street Zen moving to Hold from Sell.